AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 63 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 6.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -29.2% | 36,533 | -14.2% | 0.00% | – |
| Q4 2021 | $24,000 | -41.5% | 42,565 | +70.5% | 0.00% | – |
| Q3 2021 | $41,000 | -50.0% | 24,967 | -49.4% | 0.00% | – |
| Q2 2021 | $82,000 | +1950.0% | 49,347 | +375.8% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 10,371 | -2.6% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 10,645 | +3.2% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 10,313 | -13.9% | 0.00% | – |
| Q3 2018 | $6,000 | -73.9% | 11,976 | +14.6% | 0.00% | – |
| Q2 2018 | $23,000 | -59.6% | 10,447 | -35.7% | 0.00% | -100.0% |
| Q3 2014 | $57,000 | -65.7% | 16,255 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $166,000 | -17.0% | 19,935 | -36.7% | 0.00% | -33.3% |
| Q1 2014 | $200,000 | +52.7% | 31,498 | +80.3% | 0.00% | 0.0% |
| Q3 2013 | $131,000 | +35.1% | 17,465 | +4.4% | 0.00% | +50.0% |
| Q2 2013 | $97,000 | – | 16,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,238,322 | $4,177,000 | 1.35% |
| Noven Financial Group, Inc. | 252,667 | $326,000 | 0.22% |
| Trellus Management Company, LLC | 80,000 | $103,000 | 0.17% |
| Transform Wealth, LLC | 146,692 | $189,000 | 0.08% |
| Fort Point Capital Partners LLC | 121,400 | $157,000 | 0.08% |
| Camelot Portfolios, LLC | 36,000 | $46,000 | 0.03% |
| GHP Investment Advisors, Inc. | 90,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 328,300 | $424,000 | 0.01% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $23,000 | 0.01% |
| WealthTrust Axiom LLC | 10,000 | $12,000 | 0.01% |